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This paper reports on the modification of magnetic beads 
with oligonucleotide capture probes with a specially designed 
pendant toehold (overhang) aimed specifically to capture 
double-stranded PCR products. After capture, the PCR 
products were selectively released from the magnetic beads 
by means of a toehold-mediated strand displacement reaction 
using short artificial oligonucleotide triggers and analysed 
using capillary electrophoresis. The approach was 
successfully shown on two genes widely used in human DNA 
genotyping, namely human c-fms (macrophage colony-
stimulating factor) proto-oncogene for the CSF-1 receptor 
(CSF1PO) and amelogenin. 
Selective capture of DNA on two- and three-dimensional 
surfaces is the underlying principle of a vast majority of nucleic acid 
molecular analytical techniques such as high density microarrays, 
nucleic acid biosensors, and personalised point-of-care micro-
devices. These approaches use surfaces modified with immobilised 
capture probes for the hybridisation of nucleic acids, which is 
regarded as the final point of analysis. Patterned surface 
modification allows for the localisation of specific DNA probes at 
different regions, which in turn allows for highly efficient selection, 
separation and enrichment of complementary DNA molecules 
(targets) from the initial crude mixture.  
More recently however, in light of advances in the field of gene 
therapy,1 there has been a great deal of interest in the development of 
methods for controlled (stimuli-responsive) release of nucleic acids 
from both 2- and 3-dimensional surfaces. It is envisaged that such 
systems will facilitate the advent of smart stimuli-responsive gene 
delivery vehicles. To date, several different methods exploiting such 
external stimuli have been reported, employing the use of 
temperature,2 DC electric field,3 light,4 and low molecular weight 
organic molecules.5 Temperature controlled DNA release relies on 
thermal denaturation of DNA double helices trapped on a surface via 
immobilised ligands (capture probes), such as another DNA 
molecule6 or avidin-biotin complexes.2b This approach possesses low 
specificity and requires either harsh dehybridisation conditions or 
fine tuning of the system to be able to operate specifically at 
physiological temperatures. The application of a DC electric field 
has also shown potential for the fast and specific dehybridisation of 
3’-mismatched DNA duplexes from electro-conductive surfaces.3c 
Several publications4d-4e describe the selective release of 
multiple DNA molecules. These systems are mainly based on the use 
of gold nanoparticles with varying morphologies, and thus surface 
plasmon absorbances. Irradiation of gold nanoparticle mixtures, 
loaded with covalently captured DNA duplexes, at their specific 
plasmon resonance frequency causes preferential heating of some 
particles but not others. This consequently leads to melting of DNA 
duplexes and their subsequent release from the nanoparticle. In order 
to have specificity of DNA release, there must be no overlapping of 
the surface plasmon resonances and this is far from trivial. 
The discovery of DNA strand-displacement reactions, prompted 
by the formation of a toehold structure (for references see7), has 
opened a new era in programmable synthetic biology8. One of the 
most attractive features of this reaction is that short artificial DNA 
strands allow for a specific trigger of different downstream scenarios 
which include both nucleic acid and protein cascades.9 Applying 
these systems to solid phase supports has recently gained much 
interest.10 For example, 2-dimensional microarrays operated by a 
strand-displacement reaction were shown to be successful at DNA 
length polymorphism measurements (short tandem repeat analysis, 
STR). 10e Picuri et al9a have applied the DNA displacement reaction 
on sepharose microbeads to translate several specific biologically 
relevant DNA and RNA molecules (HIV, HCV and smallpox) into 
an unique unspecific DNA output triggering diagnostic assay. Probst 
et al10c covalently immobilised antibody encoded double stranded 
(ds)-DNA with pendant toeholds onto magnetic beads. After binding 
with specific antigens, the antibody-antigen complexes were released 
from the bead surface upon addition of specific displacement probes.  
Here we report an approach for the capture of multiple ds-DNA 
molecules on a surface of magnetic beads followed by their sequence 
selective release using a toehold-mediated strand-displacement 
reaction. To achieve this we modified magnetic beads with single-
stranded oligonucleotides (ss-ODNs) (capture probes). These capture 
probes were specially designed to capture specific ds-PCR 
amplification products, tagged with a PEGylated (polyethylene 
glycol) ss-ODN, of forensically relevant human c-fms (macrophage 
colony-stimulating factor) proto-oncogene for the CSF-1 receptor 
(CSF1PO) and amelogenin (AMEL) genes.  STR analysis using 
capillary electrophoresis (CE) is the main form of human 
COMMUNICATION Journal Name 
2 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 2012 
identification used in forensics and considered as the ‘gold standard’ 
of forensic science.11a STRs have been used in forensic science since 
1994 including the adoption of CSF1PO,11b which was developed 
originally by the Promega Corporation. This locus is an example of a 
simple repeat motif (AGAT)n and was initially incorporated into the 
US Combined DNA Index System (CODIS) loci. CSF1PO continues 
to be one of the loci used in commercial kits by the forensic 
community worldwide. Amelogenin is one of the few genes with 
homologues on the X and Y chromosomes11b and was adopted in 
1995 into STR multiplexes and used ever since. The X chromosome 
version has a 6 bp deletion compared to the Y homologue allowing 
this size variation to be used to determine the gender of the person 
from whom the DNA profile was generated. 
Each capture probe had a main hybridisation sequence (Fig. 1, 
domain a) with an extra 8 nucleotide long ss-ODN (toehold) 
attached at the 5’ termini of the main hybridisation sequence (Fig. 1, 
domain b).The entire capture probe was immobilised covalently to 
N-hydroxysuccinimide activated carboxy-terminated magnetic beads 
(1 µm, Bioclone, USA) using amide coupling through the 3’ end of 
the amine-modified capture probes. 
The synthesis of the ds-PCR products tagged with a PEGylated 
ss-ODN (Fig. 1, domain a’) has been previously described by our 
group.12 In brief, the forward primer for amplification of the target 
genes consisted of the primer’s main sequence (not shown), an 
additional shorter sequence (Fig 1, domain a’) (for hybridisation to 
the capture probe (Fig. 1, domain a)) and a PEG spacer linking at the 
5’-termini of the primer’s main sequence and the 3’-termini of the 
hybridisation sequence. At the completion of the PCR all the 
products of amplification contained a short tail of PEGylated ss-
ODN sequences (attached to the amplified ds-PCR product) which 
could be hybridised (captured) to the surface immobilised capture 
probes. Importantly, all unreacted PEGylated hairpin primers form a 
self-complementary intramolecular structure that prevents 
hybridisation of any unreacted primers with the surface immobilised 
capture probes.  
Figure 1 shows the scheme of the capture and sequence selective 
release of ds-PCR products with PEGylated ss-ODN on the magnetic 
beads. The ds-PCR product tagged with PEGylated ss-ODN tail 
(Fig. 1 domain a’) first hybridises with the capture probe covalently 
immobilised on the surface of the magnetic beads. In particular, 
during this hybridisation step the ss-ODN (domain a’) specifically 
interacts with domain a of the capture probe thus forming a perfectly 
matched DNA duplex aa’ and at the same time leaving domain b 
(toehold) free. After several washings of the magnetic beads, now 
bearing the ds-PCR product, a specific displacing sequence 
consisting of domains a’b’ is added. The domains b and b’ then 
hybridise to each other forming a toehold structure (Fig. 1 complex 
bb’) which then promotes the strand displacement of the domain a’ 
from the initial hybridisation duplex, resulting in sequence selective 
release of the ds-PCR product from the magnetic bead surface back 
into solution. The results of the displacement reactions and the 
length analysis of the released ds-PCR products were then confirmed 
using CE. 
In order to evaluate the feasibility of the approach for a one-pot 
sequence selective release of multiple hybridised ds-DNA 
molecules, we applied this technique for the capture, sequential 
release, isolation and analysis of two ds-PCR products CSF1PO and 
AMEL genes. Gene-specific capture probes with corresponding 
displacing sequences (Table S1, ESI) were designed to capture and 
release ss-ODN tagged ds-PCR products obtained after amplification 
with specific modified primers (as described above) of the CSF1PO 
and AMEL loci in human genomic DNA. Reverse primers for both 
the CSF1PO and AMEL genes were labelled with a fluorescent dye 
(fluorescein) at their 5’ termini in order to be observed during CE 
analysis. Multiplex PCR amplification with the designated primers 
(Table S1, ESI) was carried out using 5 ng of male genomic DNA 
isolated from the author’s own blood.  
In order to capture the CSF1PO and AMEL ds-PCR 
amplification products (generated from male genomic DNA) with 
PEGylated ss-ODN the PCR mixture and hybridisation buffer (final 
concentration of guanidine thiocyanate (1 M), HEPES (50 mM), pH 
7.5, and EDTA (5 mM)) were directly applied to a stoichiometric 
mixture of the magnetic beads with immobilised CSF1PO and 
AMEL capture probes. Significantly, this negates laborious and time 
consuming PCR clean-up procedures. After hybridisation (Fig. 1), 
the magnetic beads were washed multiple times by removing them 
from the hybridisation solution with a magnet and washing with a 
washing buffer (6.5×SSPE buffer pH 7.4, 0.01% Tween 20) and 
water to remove any non-hybridised ds-PCR products on the bead 
surface.  
Both the extent and stability of hybridisation were then 
determined by CE analysis. Figure 2A shows the electropherogram 
of the sequences released after 18 h (overnight) incubation of the 
magnetic bead mixture in a 1 x TEM (10 mM Tris-HCl pH 8.0, 1 
mM EDTA, 12.5 mM MgCl2) displacement buffer with no ss-ODN 
displacing sequence. Clearly, there has been no release of the ds-
PCR products from the magnetic beads indicating that no toehold 
strand displacement reaction has taken place (Fig. 2A).  
Following these results the first round of sequence selective 
release of the hybridised ds-PCR products was carried out. After 
washing, the magnetic bead mixture was resuspended in a solution at 
30 oC that consisted of a 1 x TEM displacement buffer and a 
displacing sequence (1 µM) fully complementary to the CSF1PO 
capture probe (Table S1, ESI). During this stage domain b’ of the 
CSF1PO displacing sequence binds with the domain b of the 
CSF1PO capture probe only (Fig. 1), but not the AMEL capture 
probe. Subsequently, this triggers the release of the CSF1PO ds-PCR 
product through a 3-way branch migration mechanism. An aliquot 
was taken from this reaction mixture after 0, 2, 4, 6 and 18 
(overnight) h of incubation. However, there was only a noticeable 
level of ds-PCR product released via CE analysis after 18 h 
(overnight) of incubation (for 0, 2, 4 and 6 h of displacement data 
not shown). Slow release kinetics are likely due to steric hindrance 
and electrostatic repulsions caused by the long ds-PCR products, 
ranging from 106 to 346 bp, hybridised on the magnetic bead 
surface.  
Figure 2B shows the CE electropherogram of the ds-PCR 
products present in solution after a CSF1PO displacing sequence 
was added to the magnetic bead mixture (18 h of incubation). It can 
Fig 1. Schematic of the capture of the ds-PCR products tagged with ss-ODN 
with following sequences selective release via toehold-mediated DNA strand 
displacement reaction. Domains a and a’, and b and b’ are self-
complementary. 
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clearly be seen that after incubation, two peaks with intensities of 
1094 and 1021 relative fluorescence units (RFU) of the CSF1PO ds-
PCR products were observed (Fig. 2B). The two peaks correspond to 
two different CSF1PO ds-PCR products (340 and 346 bp) amplified 
from two alleles of the CSF1PO locus. The length of these 
amplification products was in full accordance with the values 
determined by the PowerPlex 21 STR genotyping system (Promega, 
USA) (Fig. S1, ESI). Unspecific AMEL release was observed at <85 
RFU (<8.5 % of the CSF1PO intensity value) (Fig. 2B).  
The capability of the system to sequentially release a second 
hybridised ds-PCR amplification product was then evaluated. The 
same magnetic bead mixture (after CSF1PO ds-PCR products had 
been released) was rinsed thoroughly with 1×TEM buffer and 
suspended in an AMEL displacing solution consisting of 1×TEM 
buffer and AMEL displacing sequence (1 µM) (Table S1, ESI). CE 
analysis was then performed on an aliquot of the solution after 2, 4, 
6 and 18 h incubation of the magnetic beads. Surprisingly, the 
detectable level of the AMEL ds-PCR product release was achieved 
after 2 h of incubation. Figure 2C shows the CE electropherogram of 
the displaced AMEL ds-PCR product with peak intensities of 313 
and 307 RFU. In this particular case these two peaks are due to the 
amplification of the AMEL loci from the X and Y chromosomes 
(XY - male DNA genotype), respectively, previously confirmed by 
the PowerPlex 21 STR genotyping system (Fig. S1, ESI). Unspecific 
displacement of the CSF1PO amplification products was <10 RFU 
(<3% of the AMEL intensity value). 
It was believed that the difference in the displacement times 
(rates) between the first and the second rounds of the consecutive 
release were related to the washing step of the initial magnetic bead 
mixture with the washing buffer containing Tween-20 surfactant. To 
test this, the initial mixture of magnetic beads (with both PCR 
products hybridised) was washed with 1×TEM buffer only (no 
Tween-20 surfactant). The first round of the release with CSF1PO 
displacement sequence was then repeated. The CE analysis 
performed on aliquots taken in the same timeframes (2, 4, 6 and 18 
h) showed the successful displacement after 6 h of incubation (c.f 18 
h previously) with intensities of the CSF1PO peaks of 216 and 198 
RFU (Fig. S3, ESI). The observed increase in the release rate is 
likely explained by the “shielding” effect of Tween-20 physically 
adsorbed on the magnetic bead surface. This may hinder the efficient 
formation of the toehold structure and the subsequent branch 
migration displacement. The reaction timeframes are not surprising, 
since similar kinetic release (2 – 72 h) has been observed by Baker et 
al. who used 15 nucleotide long duplexes immobilised on 5 µm 
carboxylated latex particles.10a, 10b 
Our system was also capable of the simultaneous release of both 
CSF1PO and AMEL ds-PCR products from the magnetic beads. 
This was achieved by adding two displacing sequences at once 
(CSF1PO and AMEL). Figure 2D shows the CE electropherogram 
of the aliquot taken after 6 h incubation of the magnetic bead 
mixture (with both PCR products hybridised) in 1×TEM buffer 
containing SCF1PO and AMEL displacing sequences (1 µM, each). 
As expected, two peaks for each of the PCR products were observed 
with intensities of 231 and 210 RFU for CSF1PO and 132 and 163 
RFU for AMEL. The length of the released PCR products also fits 
the data shown above (Fig. 2B, Fig. 2C). 
 A final series of experiments showed the successful release of 
the surface captured ds-PCR products generated from the author’s 
female genomic DNA (Fig. S4, ESI). In this case the AMEL ds-PCR 
product was selectively released first by incubation of the hybridised 
beads in the AMEL displacing solution. CE analysis of the released 
product showed only one peak confirming the XX genotype of the 
female DNA sample (Fig. S4B). Subsequent incubation of the beads 
in the CSF1PO displacing solution resulted in the release of the 
CSF1PO ds-PCR product which was then also analysed by CE. The 
single peak observed (Fig. S4C, ESI) fits the CSF1PO genetic 
profile previously identified by the PowerPlex 21 STR genotyping 
system (Fig S2, ESI). Simultaneous release of both PCR products 
was also shown to be successful (Fig. S4C, ESI).   
 
Conclusions 
In summary, we have developed a simple DNA sequence trigger 
approach to specifically release surface hybridised ds-PCR 
amplification products. The approach is based on the specific 
reaction of toehold-mediated DNA strand-displacement. The 
selective release of one out of two surface hybridised ds-PCR 
amplification products was manipulated by simple addition of a 
specific small ss-ODN which played the role of the trigger. The 
release of the second hybridised ds-PCR product was achieved 
simply by adding another specific ss-ODN trigger. The release was 
carried out under mild conditions (low salt Tris-EDTA buffer pH 8) 
at 30 oC showing that the approach could be readily implemented in 
in vivo experiments. Isolation and analysis of the released ds-PCR 
products showed the integrity of the DNA molecules. The method 
shows great promise for a broad range of other consecutive scenarios 
such as the development of highly specific stimuli-responsive 
molecular cargo vehicles operated by DNA or RNA.  
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Fig. 2 CE electropherograms of the sequence selective release of ds-PCR 
products (generated from male DNA) dehybridised from magnetic beads 
using a toehold strand displacement reaction in the presence of (A) no 
displacing sequence, (B) a CSF1PO displacing sequence, (C) an AMEL 
displacing sequence and (D) both CSF1PO and AMEL displacing 
sequences. 
COMMUNICATION Journal Name 
4 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 2012 
1. (a) S. L. Ginn, I. E. Alexander, M. L. Edelstein, M. R. Abedi, and J. Wixon, 
J. Gene Med., 2013, 15, 65; (b) E.-Y. Kim, R. Schulz, P. Swantek, K. 
Kunstman, M. H. Malim, and S. M. Wolinsky, Gene Ther., 2012, 19, 347353. 
(c) A. G. Bader, D. Brown, J. Stoudemire, and P. Lammers, Gene Ther., 
2011, 18, 1121. 
2.  (a) A. Ohsugi, H. Furukawa, A. Kakugo, Y. Osada, and J. P. Gong, 
Macromol. Rapid Commun., 2006, 27, 1242; (b) S. H.Yeung, P. Liu, N. Del 
Bueno, S. A. Greenspoon, and R. A. Mathies, Anal. Chem., 2009, 81, 210; (c) 
N. Thaitrong, P. Liu, T. Briese, W. I. Lipkin, T. N. Chiesl, Y. Higa, and R. A. 
Mathies, Anal. Chem., 2010, 82, 10102. 
3. (a) C. Gautier, C. Cougnon, J.-F. Pilard, N. Casse, and B. Chénais, Anal. 
Chem., 2007, 79, 7920; (b) J. Wang, G. Rivas, M. Jiang, and X. Zhang, 
Langmuir, 1999, 15, 6541; (c) I. Y. Wong and N. A Melosh, Nano Lett., 
2009, 9, 3521. 
4. (a) A. Barhoumi, R. Huschka, R. Bardhan, M. W. Knight, and N. J. Halas, 
Chem. Phys. Lett., 2009, 482, 171; (b) F. L. Callari, S. Petralia, S. Conoci, 
and S. Sortino, New J. Chem., 2008, 32, 1899; (c) W. Fischer, M. A Quadir, 
A. Barnard, D. K. Smith, and R. Haag, Macromol. Biosci., 2011, 11, 1736; 
(d) A. Wijaya, S. B. Schaffer, I. G. Pallares, and K. Hamad-Schifferli, 
ACS Nano, 2009, 3, 80; (e) R. Huschka, J. Zuloaga, M. W. Knight, L. V 
Brown, P. Nordlander, and N. J. Halas, J. Am. Chem. Soc., 2011, 133, 12247; 
(f) H. de Puig, A. Cifuentes Rius, D. Flemister, S. H. Baxamusa, and K. 
Hamad-Schifferli, PLoS One, 2013, 8, e68511. 
5. (a) S. L. Ng, G. K. Such, A. P. R. Johnston, G. Antequera-García, and F. 
Caruso, Biomaterials, 2011, 32, 6277; (b)E. J. Moore, M. Curtin, J. Ionita, A. 
R. Maguire, G. Ceccone, and P. Galvin, Anal. Chem., 2007, 79, 2050. 
6. A. Bromberg, E. C. Jensen, J. Kim, Y. K. Jung, and R. A Mathies, Anal. 
Chem., 2012, 84, 963–70. 
7. (a) D. Y. Zhang and G. Seelig, Nat. Chem., 2011, 3, 103; (b) N. Srinivas, T. 
E. Ouldridge, P. Sulc, J. M. Schaeffer, B. Yurke, A. a Louis, J. P. K. Doye, 
and E. Winfree, Nucleic Acids Res., 2013, 41, 10641. 
8. (a) Prokup, J. Hemphill, and A. Deiters, J. Am. Chem. Soc., 2012, 134, 3810; 
(b) I. K. Astakhova, K. Pasternak, M. A. Campbell, P. Gupta, and J. Wengel, 
J. Am. Chem. Soc., 2013, 135, 2423. (c) J. Shin and N. Pierce, Nano 
Lett., 2004, 4, 905. 
9. (a) J. M. Picuri, B. M. Frezza, and M. R. Ghadiri, J. Am. Chem. Soc., 2009, 
131, 9368; (b) X. Qi, C. Lu, X. Liu, S. Shimron, H. Yang, and I. Willner, 
Nano Lett., 2013, 13, 4920. 
10. (a) B. A. Baker, G. Mahmoudabadi, and V. T. Milam, Colloids Surf. B. 
Biointerfaces, 2013, 102, 884; (b) B. A. Baker and V. T. Milam, Nucleic 
Acids Res., 2011, 39, e99; (c) C. E. Probst, P. Zrazhevskiy, and X. Gao, J. 
Am. Chem. Soc., 2011, 133, 17126; (d) H. Subramanian, B. Chakraborty, R. 
Sha, and N. C. Seeman, Nano Lett., 2011, 11, 910; (e) N. Pourmand, S. 
Caramuta, A. Villablanca, S. Mori, M. Karhanek, S. X. Wang, and R. W. 
Davis, Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 6146; (f) B. Frezza, S. 
Cockroft, and M. Ghadiri, J. Am. Chem. Soc., 2007, 129, 14875. 
11. (a) J. Butler, Advanced topics in forensic DNA typing: Methodology, 
Academic Press, Waltham, MA, 2011; (b) H. A. Hammond, L. Jin, Y. 
Zhong, C. T. Caskey, and R. Chakraborty, Am. J. Hum. Genet., 1994, 55, 
175; (c) K. Sullivan, A. Mannucci, C. Kimpton, and P. Gill, Biotechniques, 
1993, 15, 637.  
12. D. Khodakov, L. Thredgold, C. E. Lenehan, G. G. Andersson, H. Kobus, 
and A. V. Ellis, Biomicrofluidics, 2012, 6, 26503. 
 
